AMALGAMATED BANK - CONMED CORP ownership

CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 273 filers reported holding CONMED CORP in Q3 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.1%.

Quarter-by-quarter ownership
AMALGAMATED BANK ownership history of CONMED CORP
ValueSharesWeighting
Q3 2023$1,370
-27.4%
13,583
-2.2%
0.01%
-20.0%
Q2 2023$1,888
+31.6%
13,890
+0.5%
0.02%
+25.0%
Q1 2023$1,435
+9.9%
13,820
-6.2%
0.01%0.0%
Q4 2022$1,306
-99.9%
14,730
-0.3%
0.01%
+9.1%
Q3 2022$1,184,000
-11.8%
14,773
+5.3%
0.01%
-15.4%
Q2 2022$1,343,000
-36.7%
14,026
-1.7%
0.01%
-18.8%
Q1 2022$2,120,000
-50.2%
14,270
-52.5%
0.02%0.0%
Q4 2021$4,260,000
+112.5%
30,052
+96.1%
0.02%
-5.9%
Q3 2021$2,005,000
-6.5%
15,327
-1.7%
0.02%0.0%
Q2 2021$2,144,000
+298.5%
15,598
+278.7%
0.02%
-15.0%
Q1 2021$538,000
+7.0%
4,119
-8.4%
0.02%
+5.3%
Q4 2020$503,000
+43.7%
4,495
+0.9%
0.02%
+26.7%
Q3 2020$350,000
+5.7%
4,454
-3.2%
0.02%0.0%
Q2 2020$331,000
+13.4%
4,601
-9.9%
0.02%
+114.3%
Q1 2020$292,000
-50.8%
5,107
-3.8%
0.01%
-36.4%
Q4 2019$593,000
+22.3%
5,306
+5.2%
0.01%
+10.0%
Q3 2019$485,000
+10.5%
5,042
-1.7%
0.01%0.0%
Q2 2019$439,000
+36.8%
5,128
+32.7%
0.01%
+25.0%
Q1 2019$321,000
+33.2%
3,864
+2.8%
0.01%
+14.3%
Q4 2018$241,000
+3.4%
3,759
+27.6%
0.01%
+16.7%
Q3 2018$233,000
-17.1%
2,947
-23.2%
0.01%
-14.3%
Q2 2018$281,000
+14.7%
3,836
-1.0%
0.01%
+16.7%
Q1 2018$245,000
+22.5%
3,874
-1.4%
0.01%
+20.0%
Q4 2017$200,0003,9300.01%
Other shareholders
CONMED CORP shareholders Q3 2023
NameSharesValueWeighting ↓
HealthCor Management, L.P. 27,500$2,437,6002.23%
Ranger Investment Management 316,318$28,038,4282.08%
Lighthouse Investment Partners, LLC 142,100$12,595,7441.39%
Lighthouse Investment Partners, LLC 139,200$12,338,6881.36%
EARNEST PARTNERS LLC 2,402,352$212,944,4811.30%
Lighthouse Investment Partners, LLC 108,200$9,590,8481.06%
MOODY ALDRICH PARTNERS LLC 51,885$4,599,0860.93%
MOUNTAIN PACIFIC INVESTMENT ADVISERS INC/ID 125,435$11,118,5580.81%
Champlain Investment Partners, LLC 1,275,910$113,096,6620.72%
EPIQ PARTNERS, LLC 10,463$927,4400.62%
View complete list of CONMED CORP shareholders